Trump’s call for new medication tenders assumes that price is the aim, rather than a change in a patient’s life quality

Donald Trump’s remarks around creating “new bidding procedures for the pharmaceutical industry because they’re getting away with murder”, may have knocked US pharmaceutical stocks, but whether there is a procurement business case for putting more medication tenders to the market is debatable, says Jonathan Webb, supply chain contributor for Forbes.com The President-Elect’s January 11 comments […]

Trump’s call for new medication tenders assumes that price is the aim, rather than a change in a patient’s life quality Read More »